Enliven Therapeutics Inc.

AI Score

0

Unlock

22.64
2.18 (10.65%)
At close: Jan 15, 2025, 1:54 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -6.87 -2.71 -2.85 -16.22 -11.05 -22.86 n/a
PS Ratio n/a n/a n/a n/a n/a n/a n/a
PB Ratio 2.00 -1.33 -1.64 -15.12 -5.31 -9.85 -16.69
P/FCF Ratio -8.01 -3.13 -3.64 -34.15 -11.77 -29.53 -29.51
P/OCF Ratio -8.03 -3.19 -3.68 -36 -11.85 -29.53 -29.51
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.00 -0.00 -0.00 -0.01 n/a n/a -0.04
Quick Ratio 10.28 8.00 19.24 88.35 7.29 4.21 12.38
Current Ratio 10.28 8.00 19.24 88.35 7.29 4.21 12.38
Asset Turnover n/a n/a n/a n/a n/a n/a n/a
Interest Coverage n/a n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.29 0.49 0.58 0.93 0.48 0.43 n/a
Return on Assets (ROA) -0.26 -0.45 -0.22 -0.14 -0.7 -1.47 n/a
Return on Capital (ROIC) -0.34 -0.53 -0.23 -0.07 -0.83 -1.82 -0.95
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a